CUSIP: 869367102
Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
84,733,230
-
Total 13F shares
-
23,997,579
-
Share change
-
+12,616,282
-
Total reported value
-
$186,238,799
-
Price per share
-
$7.76
-
Number of holders
-
76
-
Value change
-
+$97,614,730
-
Number of buys
-
57
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2020
-
Previous quarter:
Q1 2020
Recent filing periods for CUSIP 869367102:
Institutional Holders of Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) as of Q2 2020
As of 30 Jun 2020,
Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,997,579 shares.
The largest 10 holders included
BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, RA CAPITAL MANAGEMENT, L.P., EcoR1 Capital, LLC, SV Health Investors, LLC, Samsara BioCapital, LLC, BAILLIE GIFFORD & CO, CITADEL ADVISORS LLC, VANGUARD GROUP INC, and BlackRock Inc..
This page lists
76
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.